The Economic Times

Trump unveils deal with Regeneron to lower drug prices as part of most-favored-nation initiative

Regeneron will reduce prices for its drugs on Medicaid. A cholesterol drug, Praluent, will be available for USD 225 on Trump's discounted drug website. This deal aims to lower healthcare costs for Americans. Regeneron also commits to significant investment in US research and development.